Arcadia Biosciences, Inc. — Director's Dealing 2018

May 16, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2018-05-12

Reporting Person: Bolles Albert D. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-05-12	Stock Option (right to buy)	$9.16	A	8210	Acquired	2028-05-12	Common Stock (8210)	Direct

Footnotes

F1: The shares subject to the Option shall vest and become exercisable in three (3) equal annual installments, with one-third of the shares subject to the Option vesting on each of the first three (3) anniversaries of the date of the award, subject to the Participant's continued service through each applicable vesting date.